| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 01/12/2005 | EP1496116A1 Anticancer agents using vero toxin variants |
| 01/12/2005 | EP1496059A1 Fused bicyclic pyrimidine derivatives |
| 01/12/2005 | EP1496057A1 Novel crystal of quinoxalinedione derivative anhydride |
| 01/12/2005 | EP1496053A1 Kappa-opioid receptor agonist comprising 2-phenylbenzothiazoline derivative |
| 01/12/2005 | EP1496052A1 Novel aminobenzamide derivative |
| 01/12/2005 | EP1495768A1 Preventives/remedies for hotflash |
| 01/12/2005 | EP1495757A1 Phosphodiesterase iv inhibitor containing pyridylacrylamide derivative |
| 01/12/2005 | EP1495756A1 Severe sepsis preventive therapeutic agent |
| 01/12/2005 | EP1495117A2 Human deubiquitinating protease gene on chromosome 7 and its murine ortholog |
| 01/12/2005 | EP1495113A2 Stimulation of nerve cell regeneration |
| 01/12/2005 | EP1495053A2 Angiopoietin-2 specific binding agents |
| 01/12/2005 | EP1495046A2 Selective melanin concentrating hormone type 1 receptor agonists |
| 01/12/2005 | EP1495042A1 Blanched polyamine steroid derivatives |
| 01/12/2005 | EP1495034A2 Mimics of acyl coenzyme-a comprising pantolactone and pantothenic acid derivatives, compositions thereof, and methods of cholesterol management and related uses |
| 01/12/2005 | EP1495031A1 Labeled oxazinocarbazoles as diagnostic agents |
| 01/12/2005 | EP1495030A1 Non-steroidal progesterone receptor modulators |
| 01/12/2005 | EP1495024A1 Dipyridodiazepinones as reverse transcriptase inhibitors |
| 01/12/2005 | EP1495023A1 Novel 1,2,3-substituted indolizine derivatives, inhibitors of fgfs, method for making same and pharmaceutical compositions containing same |
| 01/12/2005 | EP1495022A1 Diazabicyclo alkane derivatives with nk1 antagonistic activity |
| 01/12/2005 | EP1495018A1 Tricyclic thrombin receptor antagonists |
| 01/12/2005 | EP1495017A2 Novel heteroaryl alkylamide derivatives useful as bradykinin receptor modulators |
| 01/12/2005 | EP1495016A2 Heterocyclic compounds and their use as modulators of p38 map kinase |
| 01/12/2005 | EP1495009A2 Cyanamides useful as reversible inhibitors of cysteine proteases |
| 01/12/2005 | EP1495006A1 Inhibitors of glycinamide ribonucleotide transformylase |
| 01/12/2005 | EP1495004A2 Benzenesulfonamide derivatives and their use as dopamine d3 and d2 receptor ligands |
| 01/12/2005 | EP1495002A1 Benzamide derivatives useful as histone deacetylase inhibitors |
| 01/12/2005 | EP1495000A1 Alpha, omega-dicarboximide derivatives as useful uro-selective a1a adrenoceptor blockers |
| 01/12/2005 | EP1494997A1 Substituted aryl amides |
| 01/12/2005 | EP1494993A2 Novel curcumin analogues and uses thereof |
| 01/12/2005 | EP1494992A2 Carbocyclic and oxacarbocyclic fumaric acid oligomers |
| 01/12/2005 | EP1494989A2 Compounds that modulate ppar activity and methods for their preparation |
| 01/12/2005 | EP1494719A1 Injectable veterinary composition for small animals |
| 01/12/2005 | EP1494715A1 Fp receptor antagonists or pgf2 aplha antagonists for treating menorrhagia |
| 01/12/2005 | EP1494714A2 Human anti-opgl neutralizing antibodies as selective opgl pathway inhibitors |
| 01/12/2005 | EP1494713A2 Methods for treating tweak-related conditions |
| 01/12/2005 | EP1494709A2 Compositions and methods for the diagnosis and treatment of tumor |
| 01/12/2005 | EP1494706A2 Antimicrobial polymer conjugates |
| 01/12/2005 | EP1494705A1 A composition and method for killing of tumours |
| 01/12/2005 | EP1494704A1 Glp-1 agonist and cardiovascular complications |
| 01/12/2005 | EP1494701A2 Immunosuppressant compounds, methods and uses related thereto |
| 01/12/2005 | EP1494685A1 Method of treating arrhythmias comprising administration of an a1 adenosine agonist with a beta blocker, calcium channel blocker or a cardiac glycoside |
| 01/12/2005 | EP1494683A1 Method for inhibiting bone resorption with an alendronate and vitamin d formulation |
| 01/12/2005 | EP1494676A1 Fused quinoxaline derivatives as inhibitors of akt activity |
| 01/12/2005 | EP1494674A1 Carboximide derivatives as useful uro-selective alpha-1a adrenoceptor blockers |
| 01/12/2005 | EP1494670A1 Medicine for treating cancer |
| 01/12/2005 | EP1494667A1 Imidazole compounds as anti-inflammatory and analgesic agents |
| 01/12/2005 | EP1494666A1 Orally deliverable pharmaceutical composition comprising an active compound having an aminosulfonyl group (cox-2 inhibitor), a polyethylene glycol and a free-radical scavenging antioxidant |
| 01/12/2005 | EP1494664A2 Combinations of cox-2 inhibitors and other agents for the treatment of parkinson's disease |
| 01/12/2005 | EP1494663A1 Derivatives of 1-(oxoaminoacetyl) pentylcarbamate as cathepsin k inhibitors for the treatment of bone loss |
| 01/12/2005 | EP1494658A1 Natural phenolic products and derivatives thereof for protection against neurodegenerative diseases |
| 01/12/2005 | EP1494645A2 Method of treating mucus hypersecretion |
| 01/12/2005 | EP1494546A2 Method for the production of potato juice products by means of food technology |
| 01/12/2005 | EP1494542A1 Composition for modulating a physiological reaction or inducing an immune response |
| 01/12/2005 | EP1443970A4 Promoters exhibiting endothelial cell specificity and methods of using same |
| 01/12/2005 | EP1414435B1 Crystalline composition containing escitalopram |
| 01/12/2005 | EP1381605B1 Mercaptoacetylamide derivatives, a process for their preparation and their use |
| 01/12/2005 | EP1365781A4 Acrochordon alleviation |
| 01/12/2005 | EP1353918B1 Morpholine derivatives as antagonists of orexin receptors |
| 01/12/2005 | EP1305314B1 Crystalline therapeutic agent |
| 01/12/2005 | EP1299383B1 Sulfonyl-pyrrolidine derivatives useful for the treatment of neurological disorders |
| 01/12/2005 | EP1244359B1 Combination of fluazuron and ivermectin for parasite control |
| 01/12/2005 | EP1228043B1 Isoquinoline and quinazoline deivatives having a combined 5ht1a, 5ht1b and 5ht1d receptor activity |
| 01/12/2005 | EP1165532B1 Antibacterial agents |
| 01/12/2005 | EP1105370B9 Novel aryl sulphonamides and analogues |
| 01/12/2005 | EP1063987A4 Dietary control of arachidonic acid metabolism |
| 01/12/2005 | EP1030851B1 Hydroxamic and carboxylic acid derivatives having mmp and tnf inhibitory activity |
| 01/12/2005 | EP1005333B1 Methods and compositions for preventing and treating chronological aging in human skin |
| 01/12/2005 | EP0991628B1 QUINOLINE AND QUINOXALINE COMPOUNDS WHICH INHIBIT PLATELET-DERIVED GROWTH FACTOR AND/OR P56lck TYROSINE KINASES |
| 01/12/2005 | EP0979069B1 Method for producing orally administered, solid pharmaceutical products with controlled release of the active substance |
| 01/12/2005 | EP0891428B1 Phosphatidylinositol 3-kinase p110 delta catalytic subunit |
| 01/12/2005 | EP0710251B1 Assay for ykl-40 as a marker for degradation of mammalian connective tissue matrices |
| 01/12/2005 | CN1564828A Peptides acting as both GLP-1 receptor agonists and glucagon receptor antagonists and their pharmacological methods of use |
| 01/12/2005 | CN1564826A Human G-protein chemokine receptor (CCR5) HDGNR10 |
| 01/12/2005 | CN1564821A 5-methoxy-8-aryl-[1, 2, 4]triazolo[1, 5-a]pyridine derivatives as adenosine receptor antagonists |
| 01/12/2005 | CN1564820A Heterocyclic compounds for use in the treatment of disorders of the urinary tract |
| 01/12/2005 | CN1564816A Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 |
| 01/12/2005 | CN1564811A Acylsulfonamides as inhibitors of steroid sulfatase |
| 01/12/2005 | CN1564796A Stabilized compositions of aqueous reduced coenzyme Q solution |
| 01/12/2005 | CN1564786A Titanium-group metal containing high-performance water, and its producing method and apparatus |
| 01/12/2005 | CN1564696A Compositions for and methods of treating and preventing sirs/sepsis |
| 01/12/2005 | CN1564687A Use of phosphodiesterase IV inhibitors |
| 01/12/2005 | CN1564686A 8-amino- [1, 2, 4]triazolo [1, 5-a]pyridine-6-carboxylic acid amide |
| 01/12/2005 | CN1564682A Compositions for potentiating glutatthione |
| 01/12/2005 | CN1564679A Orally administered liquid compositions comprising guaifenesin and a polyoxyalkylene block copolymer |
| 01/12/2005 | CN1564678A Lipidated glycosaminoglycan particles and their use in drug and gene delivery for diagnosis and therapy |
| 01/12/2005 | CN1564676A Invert emulsion containing DHEA |
| 01/12/2005 | CN1562991A New ramification of diterpenes possessing periodic inhibitory action like matricyte of sea star egg |
| 01/12/2005 | CN1562337A Chinese traditional medicine for treating insufficiency of kidney-yang and preparaton method |
| 01/12/2005 | CN1562302A Nutritious drugs for improving children's intelligence |
| 01/12/2005 | CN1562281A Extract of cocoa tea in application for preparing medication of foodstuff of preventing and improving fatigue and clinical symptom |
| 01/12/2005 | CN1562238A Dispersion tablet of fathead tree and preparation method |
| 01/12/2005 | CN1562237A Freeze dried powder pins of fathead tree and preparation method |
| 01/12/2005 | CN1562153A Method for preparing Herba Lycopi extract with anti-oxygen dificit function |
| 01/12/2005 | CN1562136A Compound super fine dendrobium candidum soft capsule and its preparing method |
| 01/12/2005 | CN1562101A Rosa roxburghii oral liquid and its preparing method |
| 01/12/2005 | CN1562071A Use of algin oligocauharide as prebiotics |
| 01/12/2005 | CN1184215C Substd. oxazoles and thiazoles derivs. as HPPAR alpha activators |
| 01/12/2005 | CN1184214C Alpha-acyl and alpha-heteroatom-bustituted benzene acetamide glucokinase activators |
| 01/12/2005 | CN1184208C Substituted benzimidazoles and their prepn. and use |
| 01/12/2005 | CN1184204C Piperidine compounds for use as CCR-3 inhibitors |